Affinage

POLRMT

DNA-directed RNA polymerase, mitochondrial · UniProt O00411

Length
1230 aa
Mass
138.6 kDa
Annotated
2026-06-10
30 papers in source corpus 14 papers cited in narrative 14 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

POLRMT is the human mitochondrial RNA polymerase, a single-subunit enzyme homologous to bacteriophage RNA polymerases that carries out transcription of the mitochondrial genome and provides the RNA primers required to initiate mtDNA replication (PMID:9097968). Transcription initiation requires assembly of POLRMT with accessory factors at mtDNA promoters: TFAM-induced promoter bending creates a stimulatory interface between POLRMT and the upstream promoter region, while a POLRMT tether helix autoinhibits engagement of linear upstream DNA to enforce promoter specificity [PMID:bio_10.1101_2025.04.03.647028]; promoter melting then begins around position -4 through base-specific contacts of template guanines with POLRMT and a non-template adenine with TFB2M, after which de novo synthesis starts at +1 and can undergo RNA slippage [PMID:bio_10.1101_2024.12.02.626445]. During elongation POLRMT transcribes with high fidelity (~2x10^-5 error rate) but pauses at defined nucleic-acid sequence motifs and is terminated by a G-quadruplex formed at conserved sequence block 2 (CSB2); the elongation factor TEFM acts as a rheostat that suppresses pausing, raises stall force, permits error and 8-oxo-dG bypass, and overrides CSB2 termination (PMID:28882896, PMID:27436287, PMID:30514634, PMID:40958658). POLRMT is indispensable for mtDNA maintenance—its loss causes complete mtDNA depletion—and pathogenic POLRMT variants cause defective mitochondrial mRNA synthesis as a human disease mechanism (PMID:33602924, PMID:34744028). Its activity is further controlled post-translationally: succinylation at K622 disrupts binding to mtDNA and transcription factors and is restrained by SUCLG1-dependent limitation of succinyl-CoA, and POLRMT protein stability and transcriptional output depend on MRPL12 (PMID:26586915, PMID:38649537). Elevating POLRMT raises transcription initiation but not mature mRNA levels, indicating that downstream post-transcriptional steps, not initiation, limit OXPHOS biogenesis (PMID:41107062).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 1997 Medium

    Established the molecular identity of the human mitochondrial RNA polymerase, resolving which gene product transcribes the mitochondrial genome and supplies replication primers.

    Evidence cDNA cloning, sequence homology analysis, and chromosomal mapping

    PMID:9097968

    Open questions at the time
    • No in vitro enzymatic validation in this study
    • Promoter recognition and factor requirements not yet defined
  2. 2005 Low

    Raised the question of whether POLRMT has a non-mitochondrial role by reporting an intron-1-retaining transcript predicted to yield a nucleus-localized truncated protein.

    Evidence RT-PCR detection of alternative transcripts with localization inferred from absent mitochondrial targeting signal

    PMID:15773549

    Open questions at the time
    • Nuclear localization inferred from sequence, not imaged directly
    • No functional validation of a nuclear polymerase role
    • Not independently confirmed
  3. 2015 Medium

    Identified MRPL12 as a stabilizing partner of POLRMT, linking polymerase protein levels to transcriptional output.

    Evidence RNAi knockdown, co-immunoprecipitation, and mitochondrial transcription rate and protein stability assays

    PMID:26586915

    Open questions at the time
    • Structural basis of the MRPL12-POLRMT interaction not defined
    • Whether MRPL12 acts at initiation or elongation unresolved
  4. 2016 High

    Defined a sequence-encoded termination mechanism by showing the CSB2 G-quadruplex terminates POLRMT and that TEFM overrides it.

    Evidence In vitro transcription with CSB2 length variants, 3'-end mapping, and TEFM addition

    PMID:27436287

    Open questions at the time
    • How termination at CSB2 is coupled to replication priming in cells not directly tested
  5. 2017 High

    Quantified POLRMT transcriptional fidelity and error/damage bypass, and showed TEFM extends polymerase lifetime on mismatched substrates.

    Evidence In vitro transcription fidelity kinetics with and without TEFM, including 8-oxo-dG templates

    PMID:28882896

    Open questions at the time
    • In vivo consequences of misincorporation-driven bypass not established
    • No proofreading mechanism characterized
  6. 2018 High

    Resolved how TEFM enhances elongation by separating pause-free rate from pausing dynamics at single-molecule resolution.

    Evidence Single-molecule optical tweezers transcription assay measuring stall force, pause frequency, and duration

    PMID:30514634

    Open questions at the time
    • Structural basis of TEFM-modulated pausing not resolved here
  7. 2021 High

    Demonstrated POLRMT is essential for mtDNA maintenance and that human pathogenic variants act through defective transcription, establishing disease relevance.

    Evidence CRISPR knockout in cybrids with mtDNA quantification, and patient fibroblast analysis with recombinant mutant in vitro transcription

    PMID:33602924 PMID:34744028

    Open questions at the time
    • Genotype-phenotype relationships across variants not fully mapped
    • Relative contribution of transcription vs replication priming defects to disease unresolved
  8. 2024 High

    Identified succinylation at K622 as a metabolic post-translational switch that inhibits POLRMT-mtDNA/factor binding and is countered by SUCLG1.

    Evidence Mass spectrometry, K622 mutagenesis, co-IP, SUCLG1 manipulation and succinyl-CoA measurement in mouse and leukemia models

    PMID:38649537

    Open questions at the time
    • Enzyme catalyzing K622 succinylation not identified
    • Stoichiometry of succinylation in normal physiology unclear
  9. 2025 High

    Provided structural and sequence-level mechanisms for initiation and pausing: promoter bending/UPR engagement, tether-helix autoinhibition, the melting/start-site/slippage chemistry, and a consensus pause motif.

    Evidence Cryo-EM of initiation and open-to-elongation complexes with mutagenesis (preprints), plus in vitro reconstitution defining a pause consensus motif

    PMID:40958658 PMID:bio_10.1101_2024.12.02.626445 PMID:bio_10.1101_2025.04.03.647028

    Open questions at the time
    • Initiation/elongation structures from preprints await peer review
    • How pausing is regulated in vivo and integrated with TEFM not fully resolved
  10. 2025 Medium

    Showed that raising POLRMT increases initiation but not mature transcript levels, locating the rate-limiting step downstream of initiation.

    Evidence Transgenic mouse POLRMT (and POLRMT+LRPPRC) overexpression with 7S RNA and steady-state mRNA quantification

    PMID:41107062

    Open questions at the time
    • The specific post-transcriptional bottleneck not identified
    • Generality beyond the mouse model untested

Open questions

Synthesis pass · forward-looking unresolved questions
  • The molecular identity of the post-transcriptional steps that limit mature mtRNA accumulation, and the enzymes regulating POLRMT succinylation, remain unresolved.
  • No defined factor accounting for the initiation-to-mature-mRNA discrepancy
  • Succinyltransferase acting on K622 unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140098 catalytic activity, acting on RNA 5 GO:0003677 DNA binding 2 GO:0016740 transferase activity 2
Localization
GO:0005739 mitochondrion 1
Pathway
R-HSA-74160 Gene expression (Transcription) 5 R-HSA-8953854 Metabolism of RNA 3 R-HSA-69306 DNA Replication 2
Complex memberships
mitochondrial transcription initiation complex (POLRMT-TFAM-TFB2M)

Evidence

Reading pass · 14 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1997 POLRMT (h-mtRPOL) encodes the human mitochondrial RNA polymerase, a 1230 amino acid protein localized to mitochondria with sequence homology to mitochondrial RNA polymerases from lower eukaryotes and bacteriophage RNA polymerases; it carries out mitochondrial genome transcription and provides RNA primers for replication initiation. cDNA cloning, sequence analysis, chromosomal mapping (chromosome 19p13.3) Human molecular genetics Medium 9097968
2015 MRPL12 (mitochondrial ribosomal protein L12) binds and stabilizes POLRMT; knockdown of MRPL12 by RNAi causes instability of POLRMT protein (but not other primary mitochondrial transcription components) and a corresponding decrease in mitochondrial transcription rates. MRPL10 knockdown selectively degrades the mature long form of MRPL12 without affecting POLRMT. RNAi knockdown, co-immunoprecipitation, mitochondrial transcription rate measurement, protein stability assays The Journal of biological chemistry Medium 26586915
2017 POLRMT has high transcriptional fidelity (average error rate ~2×10⁻⁵), with a distinctly high propensity for GTP misincorporation opposite dT (~10⁻⁴). POLRMT also shows a high mutagenic bypass rate on 8-oxo-dG templates (~10⁻⁴ C→A error rate). TEFM increases the lifetime of POLRMT on terminally mismatched elongation substrates, allowing efficient bypass of errors and continuation of transcription. In vitro transcription fidelity assay measuring catalytic efficiencies of correct and incorrect nucleotide incorporation; kinetic analysis with and without TEFM The Journal of biological chemistry High 28882896
2016 The G-quadruplex formed between nascent RNA and non-template DNA at conserved sequence block 2 (CSB2) of human mtDNA causes transcription termination by POLRMT in vitro; longer G-tracts at CSB2 correlate with increased termination. TEFM addition prevents termination at CSB2, acting as a rheostat for POLRMT activity at this site. In vitro transcription assay with CSB2 length variants, transcript 3'-end mapping, TEFM addition experiments Nucleic acids research High 27436287
2018 TEFM enhances POLRMT transcription elongation by increasing stall force, reducing the frequency of long-lived pauses, and shortening pause durations, without changing pause-free elongation rate. POLRMT pausing dynamics at CSB2 are directly modulated by TEFM. Single-molecule optical tweezers transcription assay measuring real-time transcription dynamics, pause frequency, and pause duration with and without TEFM Biophysical journal High 30514634
2021 Recessive and dominant variants in POLRMT cause defective mitochondrial mRNA synthesis in patient fibroblasts without mtDNA deletions or copy number changes; in vitro characterization of recombinant POLRMT mutants confirms variable but deleterious effects on mitochondrial transcription, establishing defective transcription as a disease mechanism. Patient fibroblast analysis, massive parallel sequencing, in vitro transcription assays with recombinant mutant POLRMT proteins Nature communications High 33602924
2021 Knockout of POLRMT or TFB2M in human cybrid cells results in complete mtDNA loss, demonstrating that POLRMT is indispensable for maintenance of human mtDNA (required for priming of both strand-asynchronous and strand-coupled replication). CRISPR/Cas9 knockout of POLRMT and TFB2M in human cybrid cells, 2D agarose gel electrophoresis of replication intermediates, mtDNA quantification Biochimica et biophysica acta. Molecular cell research High 34744028
2024 POLRMT is succinylated at lysine 622; this succinylation disrupts POLRMT interaction with mtDNA and mitochondrial transcription factors. SUCLG1 restricts succinyl-CoA levels to suppress POLRMT succinylation, thereby maintaining mtDNA transcription and mitochondrial biogenesis. Mass spectrometry identification of succinylation site, site-directed mutagenesis (K622), co-immunoprecipitation of POLRMT with mtDNA/transcription factors, SUCLG1 knockdown/overexpression, succinyl-CoA measurement, mouse and humanized leukemia models The EMBO journal High 38649537
2025 POLRMT overexpression in mice increases mtDNA transcription initiation (elevated 7S RNA) but does not increase steady-state levels of mature mitochondrial mRNAs, indicating that post-transcriptional regulatory steps downstream of transcription initiation limit OXPHOS biogenesis. Simultaneous overexpression of POLRMT and LRPPRC also failed to increase mitochondrial transcript steady-state levels. Transgenic mouse overexpression model, RNA quantification (steady-state mRNA levels, 7S RNA), double overexpression with LRPPRC, exercise performance testing Life science alliance Medium 41107062
2025 Nucleic acid sequence determinants of POLRMT transcriptional pausing were identified: a consensus pause motif 5'-R₋₁₀NNNNNNNGT₋₁G₊₁-3' (where -1 is the 3' nascent RNA nucleotide and +1 is the incoming NTP) causes strong pausing; multiple pause sites were mapped on human mtDNA. Most pause elements are shared with multisubunit prokaryotic and nuclear RNAPs despite structural differences. In vitro reconstitution of POLRMT transcription on nucleic acid scaffolds, systematic mutational analysis of pause sequences, mapping of pause sites on human mtDNA Biochemistry High 40958658
2025 Cryo-EM structures of POLRMT transcription initiation complexes (IC3 and slipped-IC3) reveal: promoter melting begins at position −4 via base-specific interactions of −4 and −3 template guanines with POLRMT and −1 non-template adenine with TFB2M; de novo RNA synthesis begins at +1; RNA slippage occurs when synthesized 2-mer RNA shifts to −1; a non-template stabilizing loop (K153LDPRSGGVIKPP165) and Y209 from TFB2M and W1026 of POLRMT recognize the conserved non-template sequence (-1)AAA(+2). Cryo-EM structure determination of active initiation complexes; structural analysis of transcription bubble, start site selection, and slippage mechanism bioRxivpreprint High bio_10.1101_2024.12.02.626445
2025 Cryo-EM structures capturing POLRMT transitioning from open promoter complex to processive elongation complex reveal: TFAM-induced promoter bending creates a transcription-stimulatory interface between POLRMT and the upstream promoter region (UPR); UPR truncation reduces transcription from all mtDNA promoters, abolished by mutation of the POLRMT interface; the POLRMT tether helix mediates an autoinhibitory interaction with linear upstream DNA that enhances promoter specificity; deletion of the tether helix increases off-target transcription. Cryo-EM structural determination of multiple initiation complex conformations; mutational analysis of POLRMT-UPR interface and tether helix; in vitro transcription assays with truncated promoter templates bioRxivpreprint High bio_10.1101_2025.04.03.647028
2025 MD simulations indicate POLRMT translocation during elongation is coupled with NTP binding to enable fingers subdomain opening post-translocation; without NTP-coupled fingers opening, translocations proceed futilely. The coupled translocation time scale exceeds hundreds of microseconds, consistent with a postcatalytic kinetic step. This suggests a variation of Brownian ratcheting in POLRMT translocation distinct from bacteriophage T7 RNAP. All-atom molecular dynamics simulation of POLRMT elongation complexes, tICA and VAMPnet dimensional reduction analyses, comparison of pre- and post-translocation models Journal of chemical theory and computation Low 40238747
2005 An alternative transcript of POLRMT containing 225 bp of intron 1 encodes a truncated protein lacking the mitochondrial targeting signal that localizes exclusively to the nucleus, proposed to correspond to nuclear RNA polymerase IV. RT-PCR detection of alternative transcripts in HeLa, mouse, and rat cells; sequence analysis of alternative exons; cellular localization inference from absence of mitochondrial targeting signal Molekuliarnaia biologiia Low 15773549

Source papers

Stage 0 corpus · 30 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1997 Identification of the gene encoding the human mitochondrial RNA polymerase (h-mtRPOL) by cyberscreening of the Expressed Sequence Tags database. Human molecular genetics 147 9097968
2021 POLRMT mutations impair mitochondrial transcription causing neurological disease. Nature communications 54 33602924
2015 Mitochondrial Ribosomal Protein L12 Is Required for POLRMT Stability and Exists as Two Forms Generated by Alternative Proteolysis during Import. The Journal of biological chemistry 43 26586915
2017 Transcriptional fidelities of human mitochondrial POLRMT, yeast mitochondrial Rpo41, and phage T7 single-subunit RNA polymerases. The Journal of biological chemistry 34 28882896
2024 SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression. The EMBO journal 30 38649537
2016 Length heterogeneity at conserved sequence block 2 in human mitochondrial DNA acts as a rheostat for RNA polymerase POLRMT activity. Nucleic acids research 27 27436287
2023 A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth. Cell death & disease 26 36823110
2021 TFB2M and POLRMT are essential for mammalian mitochondrial DNA replication. Biochimica et biophysica acta. Molecular cell research 19 34744028
2021 Targeting Mitochondrial Metabolism and RNA Polymerase POLRMT to Overcome Multidrug Resistance in Cancer. Frontiers in chemistry 18 34976949
2023 Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer. Cell death & disease 15 37816734
2024 Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo. Cell death & disease 14 38228583
2021 POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients. Pharmaceutics 14 34834357
2022 The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth. Cell death discovery 13 35922422
2023 Targeting Mitochondrial DNA Transcription by POLRMT Inhibition or Depletion as a Potential Strategy for Cancer Treatment. Biomedicines 12 37371693
2018 TEFM Enhances Transcription Elongation by Modifying mtRNAP Pausing Dynamics. Biophysical journal 12 30514634
2024 Integrated analysis of lactate-related genes identifies POLRMT as a novel marker promoting the proliferation, migration and energy metabolism of hepatocellular carcinoma via Wnt/β-Catenin signaling. American journal of cancer research 8 38590398
2023 Expression and Purification of Recombinant Human Mitochondrial RNA Polymerase (POLRMT) and the Initiation Factors TFAM and TFB2M. Bio-protocol 8 38094251
2024 Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth. Cell death & disease 7 39227564
2025 Expanding the Genetic and Phenotypic Spectrum of POLRMT-Related Mitochondrial Disease. Clinical genetics 3 40583167
2025 Design, Optimization, and Biological Evaluation of a Novel Quinoline-Based POLRMT Inhibitor for Prostate Cancer Therapy. Journal of medicinal chemistry 3 40728385
2024 Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer. Journal of medicinal chemistry 3 39049433
2025 POLRMT enhances lenvatinib resistance in hepatocellular carcinoma cells by maintaining mitochondrial ATP production. Life sciences 2 40706667
2005 [Alternative transcripts from POLRMT responsible for synthesis of nuclear RNA polymerase IV]. Molekuliarnaia biologiia 2 15773549
2025 Collective Variables and Facilitated Conformational Opening during Translocation of Human Mitochondrial RNA Polymerase (POLRMT) from Atomic Simulations. Journal of chemical theory and computation 1 40238747
2026 Structural Basis of Mitochondrial Transcription Regulation via Interactions of PolRMT and TFAM with Upstream Promoter DNA. bioRxiv : the preprint server for biology 0 42005860
2025 Nucleic acid sequence determinants of transcriptional pausing by human mitochondrial RNA polymerase (POLRMT). bioRxiv : the preprint server for biology 0 40313918
2025 Design, Synthesis and Biological Evaluation of POLRMT Inhibitors for the Treatment of Acute Myeloid Leukemia. Chemical biology & drug design 0 40413625
2025 Nucleic Acid Sequence Determinants of Transcriptional Pausing by the Human Mitochondrial RNA Polymerase (POLRMT). Biochemistry 0 40958658
2025 POLRMT overexpression increases mtDNA transcription without affecting steady-state mRNA levels. Life science alliance 0 41107062
2025 A photoactivatable prodrug strategy toward spatially targeted inhibition of POLRMT for anticancer therapy. European journal of medicinal chemistry 0 41478007

Missed literature

Know a paper Affinage missed for POLRMT? Flag it for the maintainers and the community.

No submissions yet.